STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma

• Alexandra Fauvre,
• Margot Machu,
• Audrey Merienne,
• Nadia Vie,
• Thomas Bessede,
• Mathilde Robin,
• Veronique Garambois,
• Clara Taffoni,
• Nadine Laguette,
• Nadine Gervois‐Segain,
• Anne Jarry,
• Nathalie Labarriere,
• Yves Allory,
• Christel Larbouret,
• Laurent Gros,
• Diego Tosi,
• David B. Solit,
• Philippe Pourquier,
• Nadine Houédé,
• Celine Gongora

Affiliations

Alexandra Fauvre

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Margot Machu

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Audrey Merienne

Nantes Université, Univ Angers, INSERM, CNRS Nantes France

Nadia Vie

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Thomas Bessede

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Mathilde Robin

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Veronique Garambois

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Clara Taffoni

IGMM, Université de Montpellier, CNRS Montpellier France

Nadine Laguette

IGMM, Université de Montpellier, CNRS Montpellier France

Nadine Gervois‐Segain

Nantes Université, Univ Angers, INSERM, CNRS Nantes France

Anne Jarry

Nantes Université, Univ Angers, INSERM, CNRS Nantes France

Nathalie Labarriere

Nantes Université, Univ Angers, INSERM, CNRS Nantes France

Yves Allory

Institut Curie Paris France

Christel Larbouret

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Laurent Gros

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Diego Tosi

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

David B. Solit

Weill Cornell Med Coll New York New York USA

Philippe Pourquier

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Nadine Houédé

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France

Celine Gongora

IRCM Univ Montpellier, Inserm, ICM, CNRS Montpellier France